CT Imaging of Cancer and Normal Cells with Gold Nanoparticles as Contrast Agent: An In-Vitro Study

Article Sidebar

PDF
Published: May 31, 2022
Keywords:
Contrast agent, Diagnostic imaging, Tomography, Molecular imaging, Nanoparticles

Main Article Content

Amirah Jamil
Medical Radiation Programme, School of Health Sciences, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia
Moshi Geso
Discipline of Medical Radiation, School of Health and Biomedical Sciences, RMIT University, Bundoora VIC 3083, Melbourne, Australia
Wan Nordiana W Abd Rahman
Medical Radiation Programme, School of Health Sciences, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia

Abstract

Introduction: Computed tomography (CT) imaging has progressively developed from only structural imaging tool into hybrid diagnostic imaging such as PET-CT and SPECT to aid clinicians in diagnosis and treatment for cancer. Nowadays, researchers have found that CT might have a good prospect to become a molecular imaging modality. This research aim was to study the effects of gold nanoparticles (AuNPs) as contrast agent in computed tomography (CT) imaging. Methods: Samples of H2O, hFOB, HeLa, and MCF-7 with and without AuNPs were scanned at 80, 100, 120, and 140 kVp to investigate the influence of tube potential settings towards CT enhancement in Hounsfield (HU) unit. Regions of interests (ROIs) were drawn and the CT values were compared. Results: The results show noticeable contrast enhancements of the samples incubated with AuNPs in CT images compared to the samples without AuNPs. hFOB, HeLa, and MCF-7 with AuNPs show contrast enhancement of 1.3 to 1.5 times greater than the cell lines sam- ples without AuNPs. The outcomes also demonstrate that samples irradiated with 80 kVp yield improved CT values compared to other tube potential settings. Conclusion: The results obtained evidenced AuNPs have the potential to be a contrast agent for CT molecular imaging based on their ability in contrast enhancement.

Downloads

Download data is not yet available.

Article Details

How to Cite
Jamil, A., Geso, M., & W Abd Rahman, W. N. (2022). CT Imaging of Cancer and Normal Cells with Gold Nanoparticles as Contrast Agent: An In-Vitro Study. Malaysian Journal of Medicine and Health Sciences, 18(3). Retrieved from http://mjmhsojs.upm.edu.my/index.php/mjmhs/article/view/91
Issue
Vol. 18 No. 3 (2022)
Section
Original Articles

References

Popovtzer R, Agrawal A, Kotov NA, Popovtzer A, Balter J, Carey TE, et al. Targeted gold nanoparticles enable molecular CT imaging of cancer. Nano Lett. 2008;8(12):4593–4596.

Andreucci M, Solomon R, Tasanarong A. Side Effects of Radiographic Contrast Media: Pathogenesis, Risk Factors, and Prevention. Bio Res Int. 2014;2014:1–12.

Kojima C, Umeda Y, Ogawa M, Harada A, Magata Y, Kono K. X-ray computed tomography contrast agents prepared by seeded growth of gold nanoparticles in PEGylated dendrimer. Nanotechnology. 2010;21(24),1–5.

Huang X, Jain PK, El-Sayed IH, El-Sayed MA. Gold nanoparticles: Interesting optical properties and recent applications in cancer diagnostics and therapy. Nanomedicine. 2007;2(5):681–693.

Kircher MF, Willmann JK. Molecular Body Imaging: MR Imaging, CT, and US. Part I. Principles. Radiology. 2012;263(3):633–643.

Pan D, Williams TA, Senpan A, Allen JS, Scott MJ, Gaffney PJ, et al. Detecting vascular biosignatures with a colloidal, radio-opaque polymeric nanoparticle. J. Am. Chem. Soc. 2009;131(42):15522–15527.

Li J, Chaudhary A, Chmura SJ, Pelizzari C, Rajh T, Wietholt C, et al. A novel functional CT contrast agent for molecular imaging of cancer. Phys Med Biol. 2010;55(15):4389–4397.

Chen Z, Wang Y, Lin Y, Zhang J, Yang F, Zhou Q, et al. Advance of Molecular Imaging Technology and Targeted Imaging Agent in Imaging and Therapy. Bio Res Int. 2014;2014:1–12.

Seishima R, Okabayashi K, Hasegawa H, Tsuruta M, Hoshino H, Yamada T, et al. Computed tomography attenuation values of ascites are helpful to predict perforation site. World J Gastroenterol. 2015;21(5):1573–1579.

Lamba R, McGahan JP, Corwin MT, Li CS, Tran T, Seibert JA, et al. CT Hounsfield Numbers of Soft Tissues on Unenhanced Abdominal CT scans: Variability Between Two Different Manufacturers’ MDCT Scanners. AJR Am J Roentgenol. 2014;203(5):1013–1020.

Foroozandeh P, Aziz AA. Insight into Cellular Uptake and Intracellular Trafficking of Nanoparticles. Nanoscale Res Lett. 2018;13(1):339.

Hainfeld JF, Dilmanian FA, Slatkin DN, Smilowitz HM. J Pharm Pharmacol. 2008 Aug; 60(8):977-85.

Chithrani, B. D., Ghazani, A. A. & Chan, W. C. W. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Letters 6(4), 662–668 (2006).

Hajfathalian, M. et al. Wulff in a cage gold nanoparticle as contrast agents for computed tomography and photoacoustic imaging. Nanoscale 10(39), 18749–18757 (2018).

Chhour, P. et al. Effect of gold nanoparticle size and coating on labeling monocytes for CT tracking. Bioconjugate Chem. 28(1), 260–269 (2017).

Khademi, S. et al. Evaluation of size, morphology, concentration, and surface effect of gold nanoparticles on X-ray attenuation in computed tomography. Phys. Med. 45, 127–133 (2018).

Xu, C., Tung, G. A. & Sun, S. Size and concentration effect of gold nanoparticles on X-ray attenuation as measured on computed tomography. Chem. Mater. 20(13), 4167–4169 (2008).

Dou, Y. et al. Size-tuning ionization to optimize gold nanoparticles for simultaneous enhanced CT imaging and radiotherapy. ACS Nano 10(2), 2536– 2548 (2016).

Tonnessen BH, Pounds L. Radiation physics. J Vasc Surg. 2011 Jan;53(1 Suppl):6S-8S.

Rui X, Jin Y, FitzGerald PF, Alessio A, Kinahan P, Man BDe. (2014). Optimal kVp Selection for Contrast CT Imaging Based on a Projection- domain Method. Conf Proc Int Conf Image Form Xray Comput Tomogr. 2014; 2014:173–177.

Song K, Xu P, Meng Y, Geng F, Li J, Li Z, et al. Smart gold nanoparticles enhance killing effect on cancer cells. Int J Oncol. 2013;42(2):597-608.